Chemical synthesis of a gene encoding the human complement fragment C5a and its expression in Escherichia coli.
- 1 June 1985
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 82 (11) , 3543-3547
- https://doi.org/10.1073/pnas.82.11.3543
Abstract
A gene coding for the C5a fragment of the 5th component of human complement was chemically synthesized, cloned and expressed in E. coli. The 253-base-pair gene fragment was built through a 2-step enzymic assembly of 16 oligonucleotides, the average length of each being 32 residues. The oligonucleotides were synthesized by using the phosphoramidite method. The gene was cloned in a pBR322-derivative plasmid downstream from the lac uppromoter mutant, UV5-D. The expression of C5a was detected and measured by immunoassay and a radioligand binding assay. C5a from E. coli was comparable to C5a purified from human serum in inhibiting binding of human 125I-labeled C5a to its putative receptor on polymorphonuclear leukocytes. Studies of smooth muscle contraction in isolated guinea pig ileum showed that the recombinant C5a was biologically active and produced cross-tachyphylaxis with human serum-derived C5a. The feasibility of expressing C5a anaphylatoxin in bacteria is demonstrated and a system for mutagenesis of the C5a protein is provided.This publication has 43 references indexed in Scilit:
- Characterization of translational initiation sites inE. coliNucleic Acids Research, 1982
- Release of histamine from rat mast cells by the complement peptides C3a and C5a.1975
- Complement-Mediated Release of Histamine from Human LeukocytesThe Journal of Immunology, 1975
- Determinant of cistron specificity in bacterial ribosomesNature, 1975
- Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.1975
- Activation, activities and pharmacologically active products of complement.1974
- The Nucleotide Sequence of the Lactose Messenger Ribonucleic Acid Transcribed from the UV5 Promoter Mutant of Escherichia coliProceedings of the National Academy of Sciences, 1973
- Mechanisms of Lysosomal Enzyme Release from Human Leukocytes: Microtubule Assembly and Membrane Fusion Induced by a Component of ComplementProceedings of the National Academy of Sciences, 1973
- Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidaseJournal of Clinical Investigation, 1970
- THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENTThe Journal of Experimental Medicine, 1968